SCHEMBL30658006

SCHEMBL30658006

CC(C)(C)OC(=O)N1CC(n2ccc3nnc(Cl)cc32)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IL1B P01584 2/20 0.40
▸ P2RX7 Q99572 2/20 0.40
▸ PSEN1 P49768 1/20 0.38
▸ PSEN2 P49810 1/20 0.38
▸ APH1B Q8WW43 1/20 0.38
▸ NCSTN Q92542 1/20 0.38
▸ APH1A Q96BI3 1/20 0.38
▸ PSENEN Q9NZ42 1/20 0.38
▸ GPR119 Q8TDV5 2/20 0.37
▸ KMT2A Q03164 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HCAR1 Q9BXC0 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ SSTR4 P31391 1/20 0.36
▸ SRC P12931 3/20 0.36
▸ EGFR P00533 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ ESR2 Q92731 1/20 0.36
▸ RET P07949 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26654138 1.00 IL1B (0.40) IL1BP2RX7PSEN1PSEN2APH1B
SCHEMBL25217659 0.89 HCAR1 (0.48) GPR119HCAR1KDM4EMAPTTHRB
SCHEMBL26654108 0.81 SMARCA2 (0.52) IL1BP2RX7SRCEGFRABL1
SCHEMBL30658054 0.81 SMARCA2 (0.52) IL1BP2RX7SRCEGFRABL1
SCHEMBL34469726 0.81 OXTR (0.36) GPR119KMT2AHCAR1POLBMEN1
SCHEMBL23291564 0.78 HSP90AA1 (0.44) KMT2ALMNAPOLBSRCEGFR
SCHEMBL30658060 0.78 IL1B (0.40) IL1BP2RX7PSEN1PSEN2APH1B
SCHEMBL26653943 0.78 IL1B (0.40) IL1BP2RX7PSEN1PSEN2APH1B
SCHEMBL30658015 0.76 IL1B (0.39) IL1BP2RX7PSEN1PSEN2APH1B
SCHEMBL26653970 0.76 IL1B (0.39) IL1BP2RX7PSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522279-A1 PYRAZINE DERIVATIVES AND USES THEREOF Foghorn Therapeutics Inc. (US) 2025-03-19 — — EP disclosed
WO-2023220134-A1 PYRAZINE DERIVATIVES AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2023-11-16 — — WO disclosed
Send feedback